daily glp 1 agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy and trans GLP-1/GIP Receptor Agonists and Diabetic
Description
While genetic testing for variants linked to non response is not common, it represents the next step in helping ensure patients are given therapies that work better for them
Trends Endocrinol Amp Metab (2020) 31:41021
The LEADER CVOT trial found a higher incidence of DR-associated events in a group treated with liraglutide compared with placebo
While injectable versions captured public and clinical attention with notable weight loss outcomes, oral options introduce a new level of convenience and patient accessibility
